Table 4

Abnormal findings on 0.5 and 1.5 tesla MRI in idiopathic Parkinson’s disease (IPD), control, and multiple system atrophy (MSA) patients (average of rater 1 and rater 2)

IPDControlsMSA4-1PPV (IPD)4-152PPV (IPD+controls)4-153
0.5 Tesla n (%)322928
Infratentorial changes:
 Infratentorial signal change0 (0.0)*** 0 (0.0)** 8.5 (30.4)100.0100.0
 Any infratentorial abnormality1.5 (4.7)*** 0 (0.0)*** 18.5 (66.1)92.592.5
BG abnormalities:
 Hyperintense rim0 (0.0)*** 0 (0.0)** 8.5 (30.4)100.0100.0
 Isointense rim6 (18.8)5 (17.2)4 (14.3)40.026.7
 Relative isointensity putamen/GP3.5 (10.9)3.5 (12.1)7 (25.0)66.750.0
 Relative hypointensity putamen/GP0 (0.0)0 (0.0)0.5 (1.8)100.0100.0
 Absolute hyperintensity of putamen0 (0.0)** 0 (0.0)** 6.5 (23.2)100.0100.0
 Absolute hypointensity of putamen7 (21.9)11 (39.7)13 (46.4)65.041.9
 Putaminal atrophy0 (0.0)4-150 0 (0.0)4.5 (16.1)100.0100.0
1.5 Tesla n (%) 151616
Infratentorial changes:
 Infratentorial signal change0 (0.0)** 0.5 (3.1)4-150 6.5 (40.6)100.092.9
 Any infratentorial abnormality1 (6.7)*** 1.5 (9.4)*** 11.5 (71.9)92.082.1
BG abnormalities:
 Hyperintense rim0 (0.0)** 0 (0.0)** 6.5 (40.6)100.0100.0
 Isointense rim4 (26.7) 10.5 (71.9)7.5 (46.9)65.234.1
 Relative isointensity putamen/GP12 (80.0)8.5 (53.1)11 (68.8)47.834.9
 Relative hypointensity putamen/GP1 (6.7)0.5 (3.1)4.5 (28.1)81.875.0
 Absolute hyperintensity of putamen0 (0.0)0 (0.0)0.5 (3.1)100.0100.0
 Absolute hypointensity of putamen14 (93.3)15 (93.8)15 (93.8)51.734.1
 Putaminal atrophy0 (0.0)0 (0.0)2.5 (15.6)100.0100.0
  • 4-150 p<0.05, **p<0.01, ***p<0.001 less often than in MSA patients; p<0.05 less often than in controls.

  • 4-152 v IPD.

  • 4-153 v IPD and controls.

  • 4-1 =sensitivity, PPV=positive predictive value; BG = basal ganglia.